Conference Calls

Madrigal

‘Access to Management’ Conference Call with Madrigal (MDGL)- 4-4-17

BIOINVEST Access to Management Webinar – Madrigal (MDGL)– We are pleased to announce another BioInvest “Access to Management Call.” Below is the link to the recorded webinar presentation with the Senior Management Team of Madrigal.

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Thank you.
0 comments

‘Access to Management’ Conference Call with Anthera (ANTH) 9-1-16

BIOINVEST Access to Management Webinar – Anthera (ANTH)– We are pleased to announce another BioInvest “Access to Management Call.” Below is the link to the recorded webinar presentation with the Senior Management Team of Anthera.

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Thank you.
0 comments

‘Access to Management’ Conference Call with Novavax (NVAX) 6-3-16

BIOINVEST Access to Management Webinar – Novavax (NVAX)– We are pleased to announce another BioInvest “Access to Management Call.” Below is the link to the recorded webinar presentation with the Senior Management Team of Novavax.

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Thank you.
0 comments

MTSL Biotech Update Call 1-19-16

Conference Call – Audio Playback (for subscribers only) In light of the current market conditions, Jay Silverman and John McCamant, editors of the Medical Technology Stock Letter, held a conference call today with subscribers to discuss the following: Current market environment and outlook for biotech stocks The overall state of the Biotech Industry – Feedback[…]

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Thank you.
0 comments

‘Access to Management’ Conference Call with Novavax (12-19-14)

(for subscribers only) Listen to the ‘Access to Management’ Conference Call we had with the Novavax Management Team on Friday, December 19, 2014 where we discussed what’s in the Novavax pipeline, offered a brief R&D Summary and had a Q&A session with subscribers.        

To access this post, you must have an active subscription to the Medical Technology Stock Letter. Thank you.
0 comments